Join our community of smart investors

UDG is buying… again

The pharma services group has spent more than $275m on acquisitions so far this year
September 18, 2017

Pharmaceutical services group UDG Healthcare (UDG) continues to bulk up its portfolio through acquisition. This time around it has bought US communications business MicroMass for an initial consideration of $64m (£47m) – with another $12m up for grabs if the business reaches certain targets. The deal takes the total acquisition expenditure up to $275m in this financial year. 

IC TIP: Buy at 853p

Communications is a growing division of the global healthcare market due to its rising complexity (particularly the US) and the increase in patient input into pharmaceutical decision-making. MicroMass generates the majority of its revenue from healthcare support programmes and patient engagement and is expected to complement UDG’s existing communications division, Ashfield.